Dublin, June 13, 2022 (GLOBE NEWSWIRE) -- The "Surgical Clamps Market by Type, Usage, Material and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to ResearchAndMarkets.com's offering. The surgical clamps market was valued at $194.15 million in 2020, and is estimated to reach $260.85 million by 2030, growing at a CAGR of 2.9% from 2021 to 2030. Surgical clamps are devices for holding materials together during medical procedure. They are commonly used blood vessels for cutting blood flow and other fluids during surgery.

Majority of the clamps are look like scissors. Stainless steel is the most commonly used material in the development of a surgical clamp due to easy sterilization. One of the most common surgical clamp is known as hemostat. And used to line the incision area post-surgery. Apart from hemostat, Kelly clamp is a larger variation of the hemostat with same functionalities. Aortic clamps are used during a cardiac surgery. Intestinal clamps are made of serrated or smooth edges and used for surgery on the intestine. Growth of the global surgical clamps market is majorly driven by alarming increase in number of surgeries; rise in government initiatives for development of pharmaceutical and medical device industry; and increase in number of approvals for surgical clamps product. In addition, as per the statistics provided by the American Society of Plastic Surgeons in 2019, approximately 1.8 million cases of cosmetic minimally-invasive surgeries were performed in the U.S. The rise in demand for surgical procedures being performed by using surgical clamps.

Moreover, as per the American Cancer Society Statistics 2021, in the U.S, there were about 44,280 new cases of thyroid cancer, out of which 12,150 were in men and 32,130 in women. Furthermore, as per Organization for Economic C-operation and Development, in 2018, there were 45,307 cases of coronary artery bypass grafting procedures were performed in Germany. Hence, the increasing incidences of emergency surgeries, extensive uses of surgical clamps propels the growth of the market. Increase in government support for management of Hashimoto's thyroiditis and surge in demand for effective treatment are the major factors that drive the global surgical clamps market. In addition, key players such as Thermofisher Scientific Corporation and Integra Life Sciences, which provide numerous surgical clamps products contributes toward the market growth. Rise in demand for surgical clamps during surgical procedures act a key driving force for expansion of the global market. Cardiovascular diseases (CVDs) are the leading cause of death globally, and it takes an estimated 17.9 million lives each year. According to report of the British Heart Foundation in 2021, 7.6 million people live with heart & circulatory diseases and it causes about 25% death in the UK. Cardiovascular diseases are a group of disorders of the heart & blood vessels and it include coronary heart disease, cerebrovascular disease, rheumatic heart disease, and other conditions. Thus, rise in use of surgical clamps during cardiac surgeries expected to contribute towards the growth of surgical clamps market. However, products recall by Food Drug administration is anticipated to hinder the market growth. People, nowadays are more aware of health, which, in turn, compels them to maintain their health condition and increase demand surgical clamps. This has further encouraged many key players to enter emerging markets, thus offering a lucrative growth opportunity in the surgical clamps market. The global surgical clamps market is segmented on the basis of type, usage, material, and, end user, and region. By type, the market is categorized into hemostat clamps, aortic vascular clamps, bulldog forceps, needle holder, and others. Depending on usage, it is fragmented into disposable and reusable. As per material, it is divided into stainless steel, titanium, others. As per end user, it is divided into hospitals, ambulatory surgical centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Some of the major companies that operate in the global surgical clamps market are B.Braun Melsungen AG, Becton Dickinson and Company, Integra Life-Sciences, Mercian Surgical, Microline Surgical, Silex Medical, Sklar Surgical Corporation, Teleflex Incorporated, and Thermo Fisher Scientific. Key Benefits

This report provides an extensive analysis of the current and emerging market trends and dynamics in the global surgical clamps market to identify the prevailing opportunities.

This study presents the competitive landscape of the global market to predict the competitive environment across geographies.

Comprehensive analysis of factors that drive and restrict the market growth is provided.

Region-& country-wise analysis is provided to understand the market trends and dynamics

Key Topics Covered: CHAPTER 1: INTRODUCTION CHAPTER 2: EXECUTIVE SUMMARY CHAPTER 3: MARKET LANDSCAPE 3.1. Market definition and scope 3.2. Key findings 3.2.1. Top investment pockets 3.2.2. Top winning strategies 3.3. Porter's five forces analysis 3.4. Top player positioning, 2020 3.5. Market dynamics 3.5.1. Drivers 3.5.1.1. Increase in geriatric population 3.5.1.2. Increase in number of surgeries 3.5.1.3. Growing Incidence of Accidents and Injuries 3.5.2. Restraint 3.5.2.1. Products recalls by FDA 3.5.3. Opportunity 3.5.3.1. Increase in healthcare expenditure worldwide 3.5.4. Impact analysis 3.6. Impact analysis of COVID-19 on the surgical clamps market CHAPTER 4: SURGICAL CLAMPS MARKET, BY PRODUCT TYPE 4.1. Overview 4.1.1. Market size and forecast 4.2. Hemostat Clamps 4.2.1. Key market trends, growth factors, and opportunities 4.2.2. Market size and forecast, by region 4.2.3. Market analysis, by country 4.3. Aortic Vascular Clamps 4.3.1. Key market trends, growth factors, and opportunities 4.3.2. Market size and forecast, by region 4.3.3. Market analysis, by country 4.4. Bullodog Forceps 4.4.1. Key market trends, growth factors, and opportunities 4.4.2. Market size and forecast, by region 4.4.3. Market analysis, by country 4.5. Needle Holder 4.5.1. Key market trends, growth factors, and opportunities 4.5.2. Market size and forecast, by region 4.5.3. Market analysis, by country 4.6. Others 4.6.1. Key market trends, growth factors, and opportunities 4.6.2. Market size and forecast, by region 4.6.3. Market analysis, by country CHAPTER 5: SURGICAL CLAMPS MARKET, BY USAGE 5.1. Overview 5.1.1. Market size and forecast 5.2. DISPOSABLE 5.2.1. Market size and forecast, by region 5.2.2. Market analysis, by country 5.3. Reusable 5.3.1. Market size and forecast, by region 5.3.2. Market analysis, by country CHAPTER 6: SURGICAL CLAMPS MARKET, BY MATERIAL 6.1. Overview 6.1.1. Market size and forecast 6.2. Stainless Steel 6.2.1. Market size and forecast, by region 6.2.2. Market analysis, by country 6.3. Titanium 6.3.1. Market size and forecast, by region 6.3.2. Market analysis, by country 6.4. Others 6.4.1. Market size and forecast, by region 6.4.2. Market analysis, by country CHAPTER 7: SURGICAL CLAMPS MARKET, BY END USER 7.1. Overview 7.1.1. Market size and forecast 7.2. Hospitals 7.2.1. Market size and forecast, by region 7.2.2. Market analysis, by country 7.3. Ambulatory Surgical Centers 7.3.1. Market size and forecast, by region 7.3.2. Market analysis, by country 7.4. Others 7.4.1. Market size and forecast, by region 7.4.2. Market analysis, by country CHAPTER 8: SURGICAL CLAMPS MARKET, BY REGION CHAPTER 9: COMPANY PROFILES 9.1. B.BRAUN MELSUNGEN AG 9.1.1. Company overview 9.1.2. Company snapshot 9.1.3. Operating business segments 9.1.4. Product portfolio 9.1.5. Business performance 9.1.6. Key strategic moves and developments 9.2. BECTON & DICKINSON 9.2.1. Company overview 9.2.2. Company snapshot 9.2.3. Operating business segments 9.2.4. Product portfolio 9.2.5. Business performance 9.2.6. Key strategic moves and developments 9.3. INTEGRA LIFE SCIENCES 9.3.1. Company overview 9.3.2. Company snapshot 9.3.3. Operating business segments 9.3.4. Product portfolio 9.3.5. Business performance 9.4. MERCIAN SURGICAL 9.4.1. Company overview 9.4.2. Company snapshot 9.4.3. Operating business segments 9.4.4. Product portfolio 9.5. MICROLINE SURGICAL 9.5.1. Company overview 9.5.2. Company snapshot 9.5.3. Operating business segments 9.5.4. Product portfolio 9.6. SILEX MEDICAL 9.6.1. Company overview 9.6.2. Company snapshot 9.6.3. Operating business segments 9.6.4. Product portfolio 9.7. SKLAR SURGICAL CORPORATION 9.7.1. Company overview 9.7.2. Company snapshot 9.7.3. Product portfolio 9.8. STRYKER CORPORATION 9.8.1. Company overview 9.8.2. Company snapshot 9.8.3. Operating business segments 9.8.4. Product portfolio 9.8.5. Business performance 9.8.6. Key strategic moves and developments 9.9. TELEFLEX INCORPORATED 9.9.1. Company overview 9.9.2. Company snapshot 9.9.3. Operating business segments 9.9.4. Product portfolio 9.9.5. Business performance 9.9.6. Key strategic moves and developments 9.10. THERMOFISHER SCIENTIFIC 9.10.1. Company overview 9.10.2. Company snapshot 9.10.3. Operating business segments 9.10.4. Product portfolio 9.10.5. Business performance For more information about this report visit https://www.researchandmarkets.com/r/7qpxw0

“We are exiting that regime, and it’s going to be bumpy,” said the famous Fed watcher Mohamed El-Erian of the world where central banks let the money flow.

Buffett swapped out Wells Fargo and Goldman Sachs for a beaten-down bank.

Investors might take some comfort in crystal-ball gazing by Bank of America, which uses history to plot the next bull market.

AMD and Nvidia have been swallowed up in the bear market, with each stock declining at least 50%. Here's how to trade them now.

Already, very early signs of slowing demand and inflation are cropping up. If the economy averts all-out disaster, then stabilizing or declining rates would spur a market rebound.

It's no secret that Warren Buffett is one of the best investors alive, delivering investors returns of 20% compounded annually since becoming chief executive officer of Berkshire Hathaway in 1965. Numerous factors can explain Buffett's success, and an important one is his love of dividend stocks. Dividend stocks are a great source of returns in the market and, according to Fidelity, have accounted for 40% of the S&P 500's total returns since 1930.

A weekly look at the most important moves and news in crypto and what's on the horizon in digital assets.

(Bloomberg) -- Most Read from BloombergPutin Gets Unexpected Pushback From Ally Over War in UkraineChina Says It May Have Detected Signals From Alien CivilizationsSergey Brin Seeks Divorce, Joining Gates and Bezos in SplitMusk, Tesla, SpaceX Are Sued for Alleged Dogecoin Pyramid SchemeMonkeypox Testing Shows the US Learned Little From the Covid-19 PandemicA shareholder dispute over one of the world’s biggest copper and cobalt mines is heating up in the Democratic Republic of Congo, after state m

The cryptocurrency industry was built on swagger, enthusiasm and optimism. All three are in short supply these days, as losses and layoffs mount.

When Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) CEO Warren Buffett speaks, Wall Street and investors wisely pay close attention. While riding Buffett's coattails has been a moneymaking strategy for decades, it's equally important to take note of the stocks that the world's most successful investor and his investing team are selling or avoiding. Thus far in 2022, Warren Buffett has overseen the aggressive selling of the following five stocks.

THE MONEYIST Dear Quentin, My boyfriend and I have been together seven years, and in that time I bought a house. I used my own savings and spent about $10,000 on renovations. My house is a three-bedroom family home, and the tenants cover most of my mortgage.

Yahoo Finance's Alexis Keenan explains a lawsuit levied against Tesla, SpaceX, and Elon Musk alleging dogecoin scheme.

Elon Musk is angry. Before getting to the reason for his anger, it should be noted that for more than a decade, from 2003 to almost 2013, the billionaire and Tesla pushed hard for the adoption of electric vehicles despite mockery from rivals and skepticism from financial markets and consumers. Musk and Tesla had, however, found an ear at the White House in the person of Barack Obama, newly elected in 2008.

Exxon Mobil has gained as oil prices surged and Russia attacked Ukraine, but is XOM still a buy after Q1 earnings and softening oil prices?

(Bloomberg) -- Bitcoin fell below $20,000 for the first time since December 2020 as evidence of deepening stress within the crypto industry keeps piling up against a backdrop of monetary tightening. Most Read from BloombergPutin Gets Unexpected Pushback From Ally Over War in UkraineChina Says It May Have Detected Signals From Alien CivilizationsSergey Brin Seeks Divorce, Joining Gates and Bezos in SplitMusk, Tesla, SpaceX Are Sued for Alleged Dogecoin Pyramid SchemeMonkeypox Testing Shows the US

Hennion & Walsh CIO Kevin Mahn and Threadneedle Ventures Founder Ann Berry join Yahoo Finance Live to talk about this week's volatile market losses, which sectors investors should look into to ford recession concerns, blockchain technology across industries, and recession risks amid rising inflation and the Fed's interest rate hikes.

Would you be interested in an asset class that produces long-term returns that are nearly as good as the stock market but is as uncorrelated with the stock market as bonds are? Residential real estate, in contrast, not only resisted stocks’ decline but actually gained in value.

Don't let its share price movement fool you. This e-commerce stock is poised to bounce back in the long run.

Does the June share price for Seagen Inc. ( NASDAQ:SGEN ) reflect what it's really worth? Today, we will estimate the...

Credit Suisse has warned of a “new world order” in financial markets after central banks began aggressively ramping up interest rates.